Who owns Complete Genomics?

Key details on Complete Genomics (Ticker: GNOM)

Who owns Complete Genomics?

Is GNOM a good stock to own? Find out who bought Complete Genomics, who sold Complete Genomics (GNOM) stock, and who holds a large position in Complete Genomics.

Fund Name Number of Shares Share Valuation As Of
Essex Woodlands Health Ventures 4.45M $13.84M Sept. 30, 2012
David W. Seeley 1.47M $4.64M Dec. 31, 2012
OrbiMed Advisors 1.30M $4.04M Sept. 30, 2012
Vanguard 1.02M $3.24M Dec. 31, 2012
Oxford Asset Management 750889 $2.37M Dec. 31, 2012
Highland Capital Management 640578 $1.79M Sept. 30, 2012
Cortina Asset Management 551542 $1.56M March 31, 2012
Loeb Offshore Management 445732 $1.40M Dec. 31, 2012
Wolverine Asset Management 382935 $1.19M Sept. 30, 2012
Green Arrow Capital Management 375000 $1.18M Dec. 31, 2012
Technical Financial Services 365160 $1.07M Dec. 31, 2011
Soundpost Partners 350000 $1.08M Sept. 30, 2012
Gabelli Funds 324600 $1.02M Dec. 31, 2012
Private Wealth Partners 260100 $1.53M Sept. 30, 2011
Diamondback Capital Management 245140 $762385 Sept. 30, 2012
Frank Russell Company 196269 $612359 Dec. 31, 2012
Independence Capital Asset Partners 173470 $1.57M March 31, 2011
STATE STREET CORPORATION 155494 $438493 March 31, 2012
1798 Global Partners 146916 $430463 Dec. 31, 2011
Platinum Investment Mangement 140000 $260400 June 30, 2012
D. E. Shaw & Co 136433 $253765 June 30, 2012
Prescott Group Capital Management 118493 $347184 Dec. 31, 2011
Verition Fund Management 117000 $368550 Dec. 31, 2012
GOLDMAN SACHS 110918 $312788 March 31, 2012
Airain 100000 $315000 Dec. 31, 2012
Gilder, Gagnon, Howe & Co 96600 $304290 Dec. 31, 2012
Geode Capital Management 90872 $286246 Dec. 31, 2012
Veritable 86389 $253119 Dec. 31, 2011
Millennium Management 85547 $268617 Dec. 31, 2012
WEISS MULTI-STRATEGY ADVISERS 85000 $249050 Dec. 31, 2011
WEISS MULTI-STRATEGY ADVISERS 85000 $249050 Dec. 31, 2011
Wentworth, Hauser & Violich 74005 $233115 Dec. 31, 2012
FIRST NEW YORK SECURITIES 71600 $221244 Sept. 30, 2012
TIAA-CREF Investment Management 66976 $188872 March 31, 2012
Gabelli Securities 63846 $201114 Dec. 31, 2012
Harvest Management 63800 $200970 Dec. 31, 2012
Renaissance Technologies 63478 $199955 March 31, 2013
CalPERS 61500 $193725 Dec. 31, 2012
Bascom Hill Partners 60001 $169202 March 31, 2012
ALLIANCEBERNSTEIN 54164 $100745 June 30, 2012
Visium Asset Management 50000 $158000 Dec. 31, 2012
Ascend Capital 45870 $141738 Sept. 30, 2012
CNH Partners 45012 $139987 Sept. 30, 2012
UBS AG 42470 $133355 March 31, 2013
Parametric Portfolio Associates 39971 $123910 Sept. 30, 2012
Nomura Holdings 39769 $123283 Sept. 30, 2012

Who sold Complete Genomics?

Fund Name Date Sold Number of Shares Sold Share Valuation
AQR Capital Management Dec. 31, 2012 2.44M $7.68M
Frontier Capital Management Sept. 30, 2011 603300 $3.54M
Pier Capital Sept. 30, 2011 329751 $1.94M
Cupps Capital Management Sept. 30, 2011 247825 $1.45M
Wells Fargo & Company Sept. 30, 2011 244510 $1.44M
Magnetar Financial Sept. 30, 2011 82645 $485126
Thomas Weisel Asset Management Sept. 30, 2011 58212 $342286
Edgewood Management Sept. 30, 2011 50000 $294000
Citi Sept. 30, 2011 40104 $235009
Driehaus Capital Management June 30, 2011 362884 $5.54M
Copper Rock Capital Partners June 30, 2011 116210 $1.78M
Eudaimonia Asset Management June 30, 2011 111631 $1.71M
Allianz Global Investors of America June 30, 2011 89400 $1.37M
Tudor Investment Corporation June 30, 2011 75000 $1.15M
AH Lisanti Capital Growth June 30, 2011 62254 $951241
Credit Suisse AG June 30, 2011 55969 $855206
CITADEL ADVISORS June 30, 2011 51625 $788830
Independence Capital Asset Partners March 31, 2011 173470 $1.57M
Levin Capital Strategies March 31, 2011 95575 $863042
Austin W. Marxe and David M. Greenhouse Dec. 31, 2010 648372 $4.84M
Jennison Associates Dec. 31, 2010 324473 $2.42M